OPKO Health
OPK
$1.60
Share price
0.00%
Change (1 day)
17.65%
Change (1 year)
OPKO Health (OPK) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.61 B
According to OPKO Health 's latest financial reports the company's total liabilities are $0.61 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
OPKO Health - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.60 B | -15.24% |
| 2021-12-31 | $0.71 B | -10.84% |
| 2020-12-31 | $0.80 B | 15.41% |
| 2019-12-31 | $0.69 B | 5.26% |
| 2018-12-31 | $0.65 B | -11.59% |
| 2017-12-31 | $0.74 B | 10.6% |
| 2016-12-31 | $0.67 B | -17.69% |
| 2015-12-31 | $0.81 B | 89.81% |
| 2014-12-31 | $0.43 B | -16.71% |
| 2013-12-31 | $0.51 B | 499.12% |
| 2012-12-31 | $86.55 M | 26.15% |
| 2011-12-31 | $68.6 M | 25.21% |
| 2010-12-31 | $54.79 M | 84.47% |
| 2009-12-31 | $29.7 M | 38.77% |
| 2008-12-31 | $21.4 M | -6.05% |
| 2007-12-31 | $22.78 M | 3280.42% |
| 2006-12-31 | $0.67 M | 143.32% |
| 2005-12-31 | $0.27 M | 15.9% |
| 2004-12-31 | $0.23 M | -76.97% |
| 2003-12-31 | $1.03 M | -27.97% |
| 2002-12-31 | $1.44 M | -4.19% |
| 2001-12-31 | $1.5 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $94.83 B | 15,393.06% | 🇺🇸 USA |
 Abbott Laboratories ABT | $35.95 B | 5,773.22% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $7.25 B | 1,085.90% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $62.20 B | 10,061.90% | 🇺🇸 USA |
 LabCorp LH | $8.99 B | 1,369.29% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $4.00 B | 554.30% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $34.57 B | 5,548.91% | 🇮🇱 Israel |
 Ardelyx ARDX | $98.21 M | -83.95% | 🇺🇸 USA |